Hair Follicle Mesenchyme-Associated PD-L1 Regulates T-Cell Activation Induced Apoptosis: A Potential Mechanism of Immune Privilege

    September 2013 in “ Journal of Investigative Dermatology
    Xiaojie Wang, Alexandra K. Marr, Trisia Breitkopf, Gigi Leung, Jianqiang Hao, Eddy Wang, Nicole Kwong, Noushin Akhoundsadegh, Lieping Chen, Alice Mui, Nicholas Carr, Garth L. Warnock, Jerry Shapiro, Kevin J. McElwee
    The study investigated the immune privilege (IP) properties of cultured hair follicle (HF) cells, specifically focusing on dermal papilla and dermal sheath cup cells (DSCCs). It was found that these cells exhibited preferential expression of IP-associated genes compared to non-follicular fibroblasts (FBs), indicating potential functional IP. A key finding was the significant upregulation of programmed cell death 1 ligand 1 (PD-L1) in DSCCs and dermal papilla cells, which played a role in reducing IFNγ secretion and increasing apoptosis in co-cultured peripheral blood mononuclear cells (PBMCs). The study demonstrated that PD-L1 expression contributed to the IP properties of DSCCs by regulating T-cell activation-induced apoptosis, primarily through the mitochondrial pathway.
    Discuss this study in the Community →

    Research cited in this study

    8 / 8 results

    Related Community Posts Join

    6 / 1000+ results

    Similar Research

    6 / 1000+ results
      Proceedings of the Ninth World Congress for Hair Research 2015

      research Proceedings of the Ninth World Congress for Hair Research 2015

      January 2017 in “Journal of Investigative Dermatology Symposium Proceedings”
      The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.